The treatment of patients with aggressive non-Hodgkin's lymphoma
Armitage, J.O.
Oncology 19(4 Suppl 1: 3-6
2005
ISSN/ISBN: 0890-9091 PMID: 15934512 Document Number: 589627
Document emailed within 1 workday
Related Documents
Brice, P.; Lepage, E.; Gisselbrecht, C.; Fior, R.; Trédaniel, J.; d'Agay, M.F.; Boiron, M. 1990: Aggressive non Hodgkin lymphoma in the elderly. A retrospective study of 72 patients with clinical features and treatment Nouvelle Revue Francaise D'hematologie 32(2): 153-157Hołowiecki, J.; Giebel, S.; Walewski, J.; Krawczyk-Kuliś, M.łg.; Hellmann, A.; Skotnicki, A.; Dmoszyńska, A.; Romejko, J.; Czyz, J.ła.; Jurczak, W.; Kachel, Łu.; Wojnar, J.; Stella-Hołowiecka, B.; Saduś-Wojciechowska, M.; Sułek, K.; Jedrzejczak, W.ła.; Robak, T.; Mariańska, B.; Szczylik, C.; Warzocha, K. 2003: Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. the experience of Polish lymphoma research group Polskie Archiwum Medycyny Wewnetrznej 110(2): 863-868
Izumi, T.; Muroi, K.; Hoshino, Y.; Komatsu, N.; Ohtsuki, T.; Yamada, M.; Tomizuka, H.; Hatake, K.; Furusawa, S.; Miura, Y. 1996: Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(6): 797-800
Coiffier, B.; Reyes, F. 2005: Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective Oncology 19(4 Suppl 1: 7-15
Sehn, L.H.; Connors, J.M. 2005: Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective Oncology 19(4 Suppl. 1): 26-34
Sotnikov, V.M.; Pan'shin, G.A.; Datsenko, P.V.; Ivashin, A.V.; Smol'tsova, N.N. 2009: The role of adjuvant radiotherapy in the complex treatment of stage III-IV aggressive non-Hodgkin's lymphoma Voprosy Onkologii 55(4): 443-446
Moser, E.C.; Noordijk, E.M.; van Leeuwen, F.E.; Baars, J.W.; Thomas, Jé.; Carde, P.; Meerwaldt, J.H.; van Glabbeke, M.; Kluin-Nelemans, H.C. 2006: Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study Haematologica 91(11): 1481-1488
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Taguchi, H.; Shishido, T.; Niitsu, N.; Hiraoka, A.; Kageyama, T.; Kanamaru, A.; Ogawa, M. 1998: High-dose biweekly CHOP chemotherapy with granulocyte colony-stimulating factor support for patients with aggressive non-Hodgkin lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 523-529
Merli, F.; Federico, M.; Avanzini, P.; Ilariucci, F.; Stelitano, C.; Iannitto, E.; Colombi, M.; Vallisa, D.; Santagati, G.; Picinini, L. 1998: Weekly administration of vincristine, cyclophosphamide, mitoxantrone and bleomycin (VEMB) in the treatment of elderly aggressive non Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi Haematologica 83(3): 217-221
Ishii, K.; Yamamoto, Y.; Shigeki, T.; Kitayama, H.; Hayashi, K.; Hirose, A.; Ohta, T.; Mugitani, A.; Fujino, H.; Yagi, T.; Hirai, M.; Teshima, H.; Katsurada, T.; Urase, F.; Kitajima, H. 2005: VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(1): 39-44
Infanti, L.; Silvestri, F.; Fanin, R.; Salmaso, F.; Zaja, F.; Barillari, G.; Patriarca, F.; Geromin, A.; Cerno, M.; Damiani, D.; Baccarani, M. 1996: The F-MACHOP regimen in the treatment of aggressive non-Hodgkin's lymphomas: a single center experience in 72 patients Haematologica 81(6): 521-528
Salminen, E. 1994: The treatment of non-Hodgkin lymphoma in elderly patients Duodecim; Laaketieteellinen Aikakauskirja 110(21): 1993-1998
Doorduijn, J.K.; Sonneveld, P. 1997: Diagnosis and treatment of non-Hodgkin lymphoma in elderly patients Nederlands Tijdschrift Voor Geneeskunde 141(45): 2152-2157
Belić, A.; Popović, S.; Savić, I. 1992: Effect of polychemotherapy in the treatment of patients with non-Hodgkin's lymphoma Medicinski Pregled 45(5-6): 188-193
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91
Ali, J.; Siddiqui, N.; Hameed, A. 2016: Weight Changes in Patients with Hodgkin Lymphoma Following Treatment: Experience from a Cancer Hospital Journal of Ayub Medical College Abbottabad: Jamc 28(4): 738-741
István, L.; Balázs, L.; Brittig, F.; Pócza, K.; Szentcsiki, M.; Brenner, F. 1985: Incidence of highly malignant immunoblastic non-Hodgkin lymphoma in patients with Hodgkin's disease in remission Orvosi Hetilap 126(21): 1267-1272
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Zubrikhina, G.N.; Blindar, V.N.; Matveeva, I.I.; Demina, E.A. 2015: The characteristics of anemic syndrome in patients with prevalent phases of Hodgkin lymphoma before treatment Klinicheskaia Laboratornaia Diagnostika 60(2): 28-32